Cisplatin + RT for Triple Negative Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Dana-Farber Cancer Institute
Sponsor:
Information provided by (Responsible Party):
Jennifer Bellon, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01674842
First received: August 23, 2012
Last updated: January 19, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2018
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)